A distinguished delegation from Greater Manchester is embarking on a strategic mission to the United States, aiming to underscore the city’s prowess in the medtech sector. The team, representing Health Innovation Manchester, will engage with pivotal health innovation hubs across America.
The delegation’s primary objective is to highlight Greater Manchester’s capacity to foster groundbreaking biomedical enterprises. By participating in The MedTech Conference in San Jose and visiting renowned health innovation regions in California and Massachusetts, they plan to present Manchester as a promising hub for life science advancements. This mission is part of a larger £6 billion annual health and social care devolution initiative.
Greater Manchester offers unparalleled opportunities for partnerships in medtech and data-driven health solutions. With its pioneering spirit, the city region is an ideal location for life science businesses, offering a unique platform for testing and accelerating the adoption of novel treatments, services, and products. The area’s robust academic structure further amplifies these prospects.
By engaging with US-based medtech companies, Manchester seeks to address future healthcare demands for its nearly 3 million residents, leveraging its excellence in digital health, precision medicine, research, and informatics.
Air links established by Virgin Atlantic, connecting Manchester to major US cities like San Francisco and Boston, significantly enhance the ease of doing business between the two regions. These direct routes illustrate Manchester’s accessibility as a gateway to the wider Northern England market.
The presence of over 260 biomedical firms within the city further highlights its attractiveness for investment. Each year, Manchester’s universities contribute over 13,000 life science graduates, reinforcing a workforce exceeding 157,000 dedicated health and social care personnel.
As Manchester’s delegation visits key US cities, it aims to connect with influential stakeholders, explore partnerships, and harness digital technology’s disruptive power to enhance healthcare systems. Such ventures are crucial for Manchester’s vision of revolutionising healthcare.
With Manchester positioning itself at the intersection of science, technology, and healthcare, future prospects for collaboration and innovation appear promising.
Greater Manchester’s engagement in the US underscores its dedication to expanding its medtech and health innovation influence globally. This mission fortifies its image as a vibrant, progressive city capable of forging meaningful international partnerships.